These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3084284)

  • 1. Inability of autoimmune mice with the lpr gene to spontaneously produce interleukin 3.
    Kelley VE; Farber NM; Williams JM; Strom TB
    Eur J Immunol; 1986 Apr; 16(4):464-7. PubMed ID: 3084284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective production of interleukin 3 (IL3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in vitro by murine L3T4+ T cells: lack of spontaneous IL3 and GM-CSF production by Ly-2-/L3T4- lpr subset.
    Davignon JL; Kimoto M; Kindler V; De Kossodo S; Vassalli P; Izui S
    Eur J Immunol; 1988 Sep; 18(9):1367-72. PubMed ID: 3139430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous production of interleukin 3 by T lymphocytes from autoimmune MRL/MP-lpr/lpr mice.
    Palacios R
    Eur J Immunol; 1984 Jul; 14(7):599-605. PubMed ID: 6430708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
    Weston KM; Yeh ET; Sy MS
    J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune MRL/lpr mice sera contain IgG with interleukin 3-like activity.
    Ohta Y; Tamura S; Tezuka E; Sugawara M; Imai S; Tanaka H
    J Immunol; 1988 Jan; 140(2):520-5. PubMed ID: 3257242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
    J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signals required for activation and growth of autoimmune T lymphocytes.
    Santoro TJ; Malek TR; Rosenberg YJ; Morse HC; Steinberg AD
    J Mol Cell Immunol; 1984; 1(6):347-56. PubMed ID: 6086044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of self-reactive T cell receptor V beta regions in autoimmune mice.
    Mountz JD; Smith TM; Toth KS
    J Immunol; 1990 Mar; 144(6):2159-66. PubMed ID: 1690237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoreactive T cells in MRL/Mpr-lpr/lpr mice. Characterization of the lymphokines produced and analysis of antigen-presenting cells required.
    Weston KM; Ju ST; Lu CY; Sy MS
    J Immunol; 1988 Sep; 141(6):1941-8. PubMed ID: 3139746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells from autoimmune "IL 2-defective" MRL-lpr/lpr mice continue to grow in vitro and produce IL 2 constitutively.
    Rosenberg YJ; Steinberg AD; Santoro TJ
    J Immunol; 1984 Nov; 133(5):2545-8. PubMed ID: 6434632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of defective IL 3 responses of T lymphocytes from autoimmune mice.
    MacNeil D; Krystal G; Fairhurst M; Waterfield JD
    J Immunol; 1986 Dec; 137(11):3464-8. PubMed ID: 3491137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2 is a proliferative signal for B cells from autoimmune mice.
    Lehmann KR; Kotzin BL; Portanova JP; Santoro TJ
    Eur J Immunol; 1986 Sep; 16(9):1105-10. PubMed ID: 3093246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limiting dilution analysis of interleukin 2 and colony-stimulating factor producer cells in normal and autoimmune mice.
    Hefeneider SH; Conlon PJ; Dower SK; Henney CS; Gillis S
    J Immunol; 1984 Apr; 132(4):1863-8. PubMed ID: 6607951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual expression of IL 2 receptors and both the c-myb and c-raf oncogenes in T cell lines and clones derived from autoimmune MRL-lpr/lpr mice.
    Rosenberg YJ; Malek TR; Schaeffer DE; Santoro TJ; Mark GE; Steinberg AD; Mountz JD
    J Immunol; 1985 May; 134(5):3120-3. PubMed ID: 3920313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effect of a traditional Japanese medicine, Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan), on the hyperresponsiveness to IL-18 in autoimmune MRL/MPJ-lpr/lpr mice.
    Furuya Y; Kawakita T; Nomoto K
    Int Immunopharmacol; 2003 Mar; 3(3):365-73. PubMed ID: 12639814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineation of two defects responsible for T-cell hyporesponsiveness to concanavalin A in MRL congenic mice.
    Cameron R; Waterfield JD
    Immunology; 1986 Oct; 59(2):187-93. PubMed ID: 3095226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
    Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of L3T4+ cells in the pathogenesis of lupus in lpr-bearing mice. I. Defects in the production of interleukins 2 and 3.
    Santoro TJ; Lehmann KR; Batt RA; Kotzin BL
    Eur J Immunol; 1987 Aug; 17(8):1131-6. PubMed ID: 3113978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease.
    Perkins DL; Michaelson J; Glaser RM; Marshak-Rothstein A
    J Immunol; 1987 Sep; 139(5):1406-13. PubMed ID: 2887617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.